Skip to main content

Table 2 Summary of body weights, body weight changes, and food consumption during 14-day treatment-free recovery period

From: Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE

Group

Dose (mg/kg)

Mean body weight (g) ± SD

Body weight changes (g) ± SD Days 1–14 (n = 5)

Mean food consumption (g) ± SD Days 1–14 (n = 5)

Day 1 (n = 15)

Day 2 (n = 10)

Day 8 (n = 5)

Day 14 (n = 5)

1-F

0

212.3 ± 11.4

197.0 ± 10.9

232.4 ± 10.5

242.2 ± 13.2

+ 30.2 ± 8.9

230.6 ± 15.4

2-F

0.742

212.2 ± 13.6

195.4 ± 11.3

227.1 ± 23.6

240.9 ± 19.7

+ 29.3 ± 4.7

229.8 ± 16.9

1-M

0

295.5 ± 15.0

265.8 ± 14.1

359.7 ± 14.7

403.2 ± 21.1

+ 108.1 ± 14.8

404.0 ± 32.3

2-M

0.742

297.2 ± 17.2

265.4 ± 13.5

358.0 ± 21.1

388.5 ± 16.1

+ 86.6 ± 11.5*

365.7 ± 19.4

  1. *Significantly different from control group (p < 0.05)